AdaptHealth
AHCO · Health Care Equipment
$6.02
2.4%Globus Medical
GMED · Health Care Equipment
$81.41
0.3%The short version
- AdaptHealth is the larger business, with $3.2B of revenue in fiscal 2025 against $2.9B for Globus Medical.
- Globus Medical grew revenue faster (16.7%, against −0.5%).
- Globus Medical kept more of each dollar of sales as operating profit (16.3% operating margin, against 2.8% operating margin).
- Globus Medical turned more of its sales into free cash flow (20.0% FCF margin, against 6.8% FCF margin).
- Globus Medical earned a higher return on the capital invested in it (11.0%, against 2.1%).
| Latest fiscal year | AHCO · FY25 | GMED · FY25 |
|---|---|---|
| Size | ||
| Market cap | $819M | $11.2B |
| Revenue | $3.2B | $2.9B |
| Free cash flow | $219M | $589M |
| Net income | −$70.8M | $538M |
| Growth | ||
| Revenue growth | −0.5% | 16.7% |
| 5-year growth | 25.2% | 30.1% |
| Share count change | −0.3% | −0.6% |
| Profitability | ||
| Gross margin | 18.8% | 67.4% |
| Operating margin | 2.8% | 16.3% |
| Net margin | −2.2% | 18.3% |
| FCF margin | 6.8% | 20.0% |
| Return on capital | 2.1% | 11.0% |
| Return on equity | −4.6% | 12.3% |
| Balance sheet | ||
| Net debt | $1.7B | −$556M |
| Net debt / EBITDA | 3.6x | −0.7x |
| Dividends and buybacks | $0.0M | $301M |
| Valuation & quality | ||
| P/E | — | 20.9x |
| Piotroski F-score | 4 | 9 |
FY16
AHCO —
GMED $564M
FY17
AHCO —
GMED $636M
FY18
AHCO $345M
GMED $713M
FY19
AHCO $530M
GMED $785M
FY20
AHCO $1.1B
GMED $789M
FY21
AHCO $2.5B
GMED $958M
FY22
AHCO $3.0B
GMED $1.0B
FY23
AHCO $3.2B
GMED $1.6B
FY24
AHCO $3.3B
GMED $2.5B
FY25
AHCO $3.2B
GMED $2.9B
AHCO
GMED
FY16
AHCO —
GMED 27.3%
FY17
AHCO —
GMED 25.5%
FY18
AHCO 9.0%
GMED 23.8%
FY19
AHCO 5.6%
GMED 21.9%
FY20
AHCO 6.8%
GMED 14.1%
FY21
AHCO 9.2%
GMED 18.0%
FY22
AHCO 6.4%
GMED 22.3%
FY23
AHCO −18.7%
GMED 8.5%
FY24
AHCO 8.1%
GMED 6.6%
FY25
AHCO 2.8%
GMED 16.3%
AHCO
GMED
FY16
AHCO —
GMED $107M
FY17
AHCO —
GMED $108M
FY18
AHCO $58.5M
GMED $122M
FY19
AHCO $39.1M
GMED $101M
FY20
AHCO $156M
GMED $135M
FY21
AHCO $72.4M
GMED $219M
FY22
AHCO −$17.6M
GMED $104M
FY23
AHCO $143M
GMED $165M
FY24
AHCO $236M
GMED $405M
FY25
AHCO $219M
GMED $589M
AHCO
GMED
FY16
AHCO —
GMED 14.4%
FY17
AHCO —
GMED 12.7%
FY18
AHCO —
GMED 16.6%
FY19
AHCO 12.0%
GMED 14.5%
FY20
AHCO 9.2%
GMED 8.3%
FY21
AHCO 7.3%
GMED 12.0%
FY22
AHCO 3.4%
GMED 13.2%
FY23
AHCO −12.0%
GMED 3.7%
FY24
AHCO 5.2%
GMED 3.7%
FY25
AHCO 2.1%
GMED 11.0%
AHCO
GMED
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.